- Home
- BSET vs GNLX Comparison
BSET vs GNLX Comparison
Compare BSET & GNLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BSET | GNLX |
|---|---|---|
| Founded | 1902 | 2001 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Home Furnishings | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 125.0M | 113.6M |
| IPO Year | 1995 | 2022 |
Fundamental Metrics
Financial Performance| Metric | BSET | GNLX |
|---|---|---|
| Price | $14.57 | $2.88 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $17.25 |
| AVG Volume (30 Days) | 19.7K | ★ 155.2K |
| Earning Date | 04-01-2026 | 05-12-2026 |
| Dividend Yield | ★ 5.49% | N/A |
| EPS Growth | ★ 163.06 | 9.47 |
| EPS | ★ 0.13 | N/A |
| Revenue | ★ $456,855,000.00 | $8,000.00 |
| Revenue This Year | $1.72 | N/A |
| Revenue Next Year | $3.78 | N/A |
| P/E Ratio | $112.31 | ★ N/A |
| Revenue Growth | ★ 0.96 | N/A |
| 52 Week Low | $13.17 | $2.29 |
| 52 Week High | $19.75 | $8.54 |
Technical Indicators
Market Signals| Indicator | BSET | GNLX |
|---|---|---|
| Relative Strength Index (RSI) | 56.53 | 53.83 |
| Support Level | $14.38 | $2.39 |
| Resistance Level | $14.77 | $2.97 |
| Average True Range (ATR) | 0.32 | 0.22 |
| MACD | 0.04 | -0.01 |
| Stochastic Oscillator | 72.67 | 37.04 |
Price Performance
Historical ComparisonAbout BSET Bassett Furniture Industries Incorporated
Bassett Furniture Industries Inc is a manufacturer, marketer, and retailer of home furnishings products in the United States. It operates through the following segments: The Wholesale segment focuses on the design, manufacture, sourcing, sale, and distribution of furniture products, the Retail segment which consists of company-owned stores, and the Corporate and others segment. Majority of revenue is from Wholesale sales of furniture and accessories.
About GNLX Genelux Corporation
Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec), Lung, and Pancreatic Cancer.